Home > Drug Search >
  • company_query: Biofabri
  •   > 
Drug Filter
Category:
chemistry (5) biology (30)
Status:
Approved (8) BLA Filing (1) Phase Ⅲ (4) Phase Ⅱ (14) Phase Ⅰ (7)
Clinical Stage:
Pending (3) Active (19) Discontinued (5)
Bio-Type:
Cell therapy (2) Vaccine (17) Blood extraction (1) Recombinant coagulation factor (1) Recombinant cytokines (3) Recombinant hormone (1) Whole antibody (2)
Indication:
Acute myeloid Leukemia (AML) (1) Breast cancer (3) Crohn's disease (1) Cholera (1) Uveal melanoma (1) Endometrial cancer (1) Gastric cancer (1) Wet age-related macular degeneration (1) HBV infection (2) HIV infection (2) Hypertension (1) Major depressive disorder (MDD) (1) Melanoma (2) Multiple myeloma (MM) (1) Multiple sclerosis (MS) (2) Non small cell lung cancer (NSCLC) (2) Factor X deficiency (1) Ovarian cancer (1) Pancreatic cancer (1) Peptic ulcer (1) Psoriatic arthritis (1) Renal cell carcinoma (2) Rheumatoid arthritis (RA) (1) Rectal fistula (1) Norovirus infections (2) Systemic lupus erythematosus (1) Tuberculosis (1) Ulcerative colitis (1) Influenza A virus infections (3) Ankylosing Spondylitis (AS) (1) Cirrhosis (1) Chronic heart failure (1) Stroke (1) Hemophilia B (1) Congenital factor VII deficiency (1) Neutropenia (1) Portal hypertension (1) Acute heart failure (1) Ischemia-reperfusion injury (1) Plaque psoriasis (1) Bleeding (1) Coronary heart disease (1) Hemophilia (1)
Others:
Sort: Aprv. Year Alphabetical Prev Next
First Prev 1 2 Next Last GO
Recently Viewed Drugs:
Insert title here
Feed-Back To Top
ICP Permit 14047345| Beijing PSB Hai Dian Record 11010802017043 |(京)-经营性-2015-0023(互联网药品信息服务资格证书)
Insert title here
Feed-Back To Top